Fabienne Schochter

11PUBLICATIONS
47CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Obstetrics and gynaecologyCancer geneticsSemi- and unsupervised learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 16, 2026
Efficacy, safety and circulating tumor cell dynamics in patients treated with Eribulin for HER2-negative advanced breast cancer - results from the phase II DETECT IVb trial.

|Oct 15, 2025
Rare abdominal wall clear cell carcinoma in endometriosis: case report and literature review of diagnostic and therapeutic considerations.

Davut Dayan, Lisa Wisniewski, Andrea Formentini

|Aug 01, 2024
Pregnancy after advanced ovarian cancer with spontaneous uterine rupture in second trimester: A case report and review of the literature.

Stefan Lukac, Robin Wenzel, Fabienne Schochter

|Sep 05, 2023
Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer.

Ignace Vergote, Jose Alejandro Pérez-Fidalgo, Erika Paige Hamilton

|Aug 12, 2023
Which Patients Do We Need to Test for BRCA1/2 Mutation? Feasibility of Adjuvant Olaparib Treatment in Early Breast Cancer-Real-World Data from Two Large German Breast Centers.

Dominik Dannehl, Tobias Engler, Léa Louise Volmer

|Aug 26, 2022
Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis-Results from the Adjuvant SUCCESS A Trial.

Elisabeth K Trapp, Peter A Fasching, Tanja Fehm

Pageof 2

Frequent Collaborators

3 joint publications

Wolfgang Janni

2 joint publications

Florian Ebner

2 joint publications

Stefan Lukac

2 joint publications

Thomas W P Friedl